Poly(vinyl alcohol) nanoparticle stability in biological media and uptake in respiratory epithelial cell layers in vitro

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 72, Issue 2, 2009, Pages 438-443

  Madlova, M ^a   Jones, S A ^a   Zwerschke, I ^a   Ma, Y ^a   Hider, R C ^a   Forbes, B ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Airways; Calu 3; Drug delivery; Nanoparticle; Translocation; Uptake

Indexed keywords

BALANCED SALT SOLUTION; CARBOXYFLUORESCEIN; NANOPARTICLE; POLYVINYL ALCOHOL;

ARTICLE; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; DRUG DETERMINATION; DRUG LABELING; DRUG STABILITY; DRUG SYNTHESIS; DRUG UPTAKE; ELECTRICITY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; NANOFABRICATION; PROTEIN TRANSPORT; RESPIRATORY EPITHELIUM; SURFACE PROPERTY; BRONCHUS; CELL CULTURE; CELL LINE; CYTOLOGY; METABOLISM; SPECTROFLUOROMETRY;

BRONCHI; CELL LINE; CELLS, CULTURED; EPITHELIAL CELLS; HUMANS; NANOPARTICLES; POLYVINYL ALCOHOL; SPECTROMETRY, FLUORESCENCE; SURFACE PROPERTIES;

EID: 67349179948     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2009.01.009     Document Type: Article

References (36)

1. Oberdorster G., Oberdorster E., and Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 113 (2005) 823-839
2. Heyder J., Gebhart J., Rudolf G., and Shiller C.F. Deposition of particles in the human respiratory tract in the size range 0.005-15 μm. J. Aerosol. Sci. 17 (1986) 811-825
3. Emerich D.F., and Thanos C.G. Targeted nanoparticle-based drug delivery and diagnosis. J. Drug Target 15 (2007) 163-183
4. Vauthier C., Cabane B., and Labarre B.D. How to concentrate nanoparticles and avoid aggregation?. Eur. J. Pharm. Biopharm. 69 (2008) 466-475
5. Rodoslav S., Laibain L., Eisenberg A., and Duisica M. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science 300 (2003) 615-618
6. 14C]-poly(lactic acid) nanoparticles coated with albumin after parenteral administration to rats. Biomaterials 13 (1992) 1093-1102
7. Rogueda P.G.A., and Traini D. The nanoscale in pulmonary delivery. Part 2: Formulation platforms. Exp. Opin. 4 (2007) 607-620
8. Kraft W.K., Steiger B., Beussink D., Quiring J.N., Fitzgerald N., Greenberg H.E., and Waldman S.A. The pharmacokinetics of nebulised nanocrystal budesonide suspension in healthy volunteers. J. Clin. Pharm. 44 (2004) 67-72
9. Kawashima Y., Yamamoto H., Takeuchi H., Fuioka S., and Hinto T. Pulmonary delivery of insulin with nebulised dl-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycaemic effect. J. Control. Release 62 (1999) 279-287
10. Pandy R., and Khuller G.K. Antitubercular inhaled therapy: opportunities, progress and challenges. J. Antimicrob. Chemother. 55 (2005) 430-435
11. J.T. McConville, K.A. Overhoff, P. Sinswat, Delivery of nebulised itraconazole nanoparticles in the murine model, in: R.N. Dalby, R.P. Byron, J. Peart, J.D. Sunman (Eds.), Respiratory Drug Delivery Europe, vol. 1, Davis Healthcare International Publishing, Illionois, 2005, pp. 281-283.
12. Kato T., Yashiro T., Murata Y., Herber D.C., Oshikawa K., Bando M., Ohno S., and Sugiyama Y. Evidence that exogenous substances can be phagocytised by alveolar epithelial cells and transported into blood capillaries. Cell Tissue Res. 311 (2003) 47-51
13. Bajanowski T., Brinkmann B., Stefanec A.M., Barckhaus R.H., and Fechner G. Detection and analysis of tracers in experimental drowning. Int. J. Legal Med. 111 (1998) 57-61
14. Kreyling W.G., Semmler M., Erbe F., Mayer P., Takenaka S., and Schultz H. Translocation of ultrafine insoluble iridium particles from the lung epithelium to extrapulmonary organs is size dependant but very low. J. Toxicol. Environ. Health A 65 (2002) 1513-1530
15. König M.F., Lucocq J.M., and Weibel E.R. Demonstration of pulmonary vascular perfusion by electron and light microscopy. J. Appl. Physiol. 75 (1993) 1877-1883
16. Yacobi N.R., Demaio L., Xie J., Hamm-Alvarez S.F., Kim K.J., and Crandell E.D. Polystyrene nanoparticles trafficking across alveolar epithelium. Nanomedicine 4 (2008) 139-145
17. Mills N.L., Amin N., Robinson S.D., Anand A., Davies J., Patel D., de la Fuente J.M., Cassee F.R., Boon N.A., MacNee W., Millar A.M., Donaldson K., and Newby D.E. Do inhaled carbon nanoparticles translocate directly into the circulation of humans?. Am. J. Respir. Crit. Care Med. 173 (2006) 426-431
18. Videira M.A., Botelho M.F., Santos A.C., Gouveia L.F., De Lima J.J.P., and Almedia A.J. Lymphatic uptake of pulmonary delivered radiolabelled solid lipid nanoparticles. J. Drug Target 10 (2002) 607-613
19. Nemmar A., Hoet P.H.M., Vanquickenborne B., Dinsdale D., Thomeer M., Hoylaerts M.F., Vanbilloen H., Mortelmans L., and Nemery B. Passage of inhaled particles into the blood circulation in humans. Circulation 105 (2002) 411-414
20. Berry J.P., Arnoux B., Stanislas G., Galle P., and Chrtien J. Microanalytic study of particle transport across alveoli-role of blood platelets. Biomed. Express 27 (1977) 354-357
21. M. Gul, S.A. Jones, L.A. Dailey, Y. Maa, A. Aramanb, F. Sadouki, R. Hider, B. Forbes, A poly(vinyl alcohol) nanoparticle platform for kinetic studies of inhaled particles, Inhaled Toxic., in press.
22. Chana J., Forbes B., and Jones S.A. The synthesis of high molecular weight partially hydrolysed poly(vinyl alcohol) grades suitable for nanoparticle generation. J. Nanosci. Nanotechnol. 8 (2008) 5739-5747
23. Grainger C., Greenwell L.L., Lockley D.J., Martin G.P., and Forbes B. Culture of Calu-3 cells at the air-liquid interface provides a representative model of the airway epithelial barrier. Pharm. Res. 23 (2006) 1482-1490
24. Grenha A., Grainger C.I., Daily L.A., Seijo B., Martin G.P., Remunan-Lopez C., and Forbes B. Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro. Eur. J. Pharm. Sci. 31 (2007) 73-84
25. Jones S.A., Brown M.B., and Martin G.P. Determination of polyvinyl alcohol using gel filtration liquid chromatography. Chromatographia 59 (2004) 43-46
26. Jones S.A., Martin G.P., and Brown M.B. Manipulation of beclomethasone-hydrofluoroalkane interactions using biocompatible macromolecules. J. Pharm. Sci. 95 (2006) 160-1073
27. Buttini F., Colombo P., Wenger M., Mesquida P., Marriott C., and Jones S.A. Back to basics: the development of a simple, homogenous, two-component dry powder inhaler formulation for the delivery of budesonide using miscible vinyl polymers. J. Pharm. Sci. 97 (2008) 1257-1267
28. Jones S.A., Mesgarpour S., Chana J., and Forbes B. Preparation and characterisation of polymeric nanoparticles using low molecular weight poly(vinyl alcohol). J. Biomed. Nanotechnol. 4 (2008) 319-325
29. Lyoo W.S., and Lee H.W. Synthesis of high-molecular-weight poly(vinyl alcohol) with high yield by novel one-batch suspension polymerization of vinyl acetate and saponification. Colloid Polym. Sci. 280 (2002) 835-840
30. Pashley R.M. Hydration forces between mica surfaces in aqueous electrolyte solutions. J. Colloid Interface Sci. 83 (1981) 531-546
31. Sporty J.L., Horalkova L., and Ehrhardt C. In vitro cell culture models for the assessment of pulmonary drug disposition. Exp. Opin. Drug Metab. Toxicol. 4 (2008) 333-345
32. Geys J., Coenegrachts L., Vercammen J., Engelborghs Y., Nemmar A., Nemery B., and Hoet P.H.M. In vitro study of the pulmonary translocation of NPs: a preliminary study. Toxicol. Lett. 160 (2006) 218-226
33. Rejman J., Oberle V., Zuhorn I.S., and Hoekstra D. Size dependent internalisation of particles via the pathways of clathrin and caveolae mediated endocytosis. J. Biochem. 377 (2004) 159-169
34. Bradbury N.A., Clark J.A., Watkins S.C., Widnell C.C., Smith H.S., and Bridges R. Characterization of the internalization pathways for the cystic fibrosis transmembrane conductance regulator. Am. J. Physiol.: Lung Cell. Mol. Physiol. 276 (1999) L659-L668
35. Radomski A., Jurasz P., Alonso-Escolano D., Drews M., Morandi M., Malinski T., and Radomski M.W. Nanoparticle-induced platelet aggregation and vascular thrombosis. Br. J. Pharmacol. 146 (2005) 882-893
36. Medina C., Santos-Martinez M.J., Radomski A., Corrigan O.I., and Radomski M.W. Nanoparticles: pharmacological and toxicological significance. Br. J. Pharmacol. 150 (2007) 552-558